evidenceId,evidenceType,shortDesc,desc,id,lastEdit,status,gene/entrezGeneId,gene/hugoSymbol,gene/name,gene/oncogene,gene/curatedIsoform,gene/curatedRefSeq,gene/tsg,articles/0/pmid,articles/0/title,articles/0/journal,articles/0/pubDate,articles/0/volume,articles/0/issue,articles/0/pages,articles/0/authors,articles/0/elocationId,articles/0/link,articles/0/reference,articles/0/abstract,articles/1/pmid,articles/1/title,articles/1/journal,articles/1/pubDate,articles/1/volume,articles/1/issue,articles/1/pages,articles/1/authors,articles/1/elocationId,articles/1/link,articles/1/reference,articles/1/abstract,articles/2/pmid,articles/2/title,articles/2/journal,articles/2/pubDate,articles/2/volume,articles/2/issue,articles/2/pages,articles/2/authors,articles/2/elocationId,articles/2/link,articles/2/reference,articles/2/abstract,articles/3/pmid,articles/3/title,articles/3/journal,articles/3/pubDate,articles/3/volume,articles/3/issue,articles/3/pages,articles/3/authors,articles/3/elocationId,articles/3/link,articles/3/reference,articles/3/abstract
17840,GENE_BACKGROUND,,"INPP4B is a lipid inositol polyphosphate 4-phosphatase that has a role in negatively regulating the PI3K/AKT signaling pathway. The primary function of INPP4B is to selectively hydrolyze the position 4 phosphate group on the inositol ring, converting PI(3,4)P2 to PI(3)P (PMID: 24069021). INPP4B has been implicated in the suppression of cell proliferation, cell motility and tumor growth in mice via control of the PI3K/AKT pathway (PMID: 21127264, 19325558, 24069021). INPP4B loss of heterozygosity has been identified in breast and ovarian cancer patients, suggesting that INPP4B functions as a tumor suppressor (PMID: 19647222, 21127264). Loss-of-function studies in breast cancer cell line and murine models demonstrate that reduced expression of INPP4B results in enhanced AKT expression, cell invasiveness, and tumor progression (PMID: 19647222). Loss of INPP4B expression is observed in breast, ovarian, and prostate cancers, and correlates with lower overall survival (PMID 19647222).",,2017-10-04,,8821,INPP4B,inositol polyphosphate-4-phosphatase type II B,False,ENST00000262992,NM_001101669.1,True,19325558,Regulation of PI(3)K/Akt signalling and cellular transformation by inositol polyphosphate 4-phosphatase-1.,EMBO reports,2018-05-01T20:09:00,10,5,487-93,Ivetac I et al,doi: 10.1038/embor.2009.28,,0001-05-01,,24069021,Role of inositol poly-phosphatases and their targets in T cell biology.,Frontiers in immunology,2018-09-23T20:13:00,4,,288,Srivastava N et al,doi: 10.3389/fimmu.2013.00288,,0001-09-23,,21127264,Inositol polyphosphate 4-phosphatase II regulates PI3K/Akt signaling and is lost in human basal-like breast cancers.,Proceedings of the National Academy of Sciences of the United States of America,2017-12-21T20:10:00,107,51,22231-6,Fedele CG et al,doi: 10.1073/pnas.1015245107,,0001-12-21,,19647222,Evidence that inositol polyphosphate 4-phosphatase type II is a tumor suppressor that inhibits PI3K signaling.,Cancer cell,2018-08-04T20:09:00,16,2,115-25,Gewinner C et al,doi: 10.1016/j.ccr.2009.06.006,,0001-08-04,
17839,GENE_SUMMARY,,"INPP4B encodes a tumor suppressor involved in regulation of the phosphatidylinositol signaling pathway. Overexpression and deletion of INPP4B are found in leukemia, breast, ovarian and prostate cancers.",,2017-04-05,,8821,INPP4B,inositol polyphosphate-4-phosphatase type II B,False,ENST00000262992,NM_001101669.1,True,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
